Ultralow-dose estradiol for preventing bone loss

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1403, 2003-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flaxseed Does not Antagonize the Effect of Ultra-Low-Dose Estrogen Therapy on Bone Mineral Density and Biomechanical Bone Strength in Ovariectomized Rats

By Sacco Sandra Jiang Jessica Reza-Lopez Sandra Ma David Thompson Lilian Ward Wendy

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 20, 2009-01 ,pp. : 1209-1216

Taylor & Francis Ltd

Access to resources Recommend Favorite

Recommendations for preventing, treating corticosteroid-induced bone loss

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Oxytrex^®: an oxycodone and ultra-low-dose naltrexone formulation

By Webster Lynn R

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1277-1283

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic acid cost effective in preventing AI-associated bone loss

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Low-dose estrogens prevent bone loss in postmenopausal women

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite